218 related articles for article (PubMed ID: 24311705)
1. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.
Kennedy DJ; Fan Y; Wu Y; Pepoy M; Hazen SL; Tang WH
Clin J Am Soc Nephrol; 2014 Mar; 9(3):462-7. PubMed ID: 24311705
[TBL] [Abstract][Full Text] [Related]
2. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
Kennedy DJ; Tang WH; Fan Y; Wu Y; Mann S; Pepoy M; Hazen SL
J Am Heart Assoc; 2013 Apr; 2(2):e000104. PubMed ID: 23557751
[TBL] [Abstract][Full Text] [Related]
3. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
4. 24-hour urine phosphorus excretion and mortality and cardiovascular events.
Palomino HL; Rifkin DE; Anderson C; Criqui MH; Whooley MA; Ix JH
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1202-10. PubMed ID: 23539231
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
6. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis.
Hasegawa M; Ishii J; Kitagawa F; Kanayama K; Takahashi H; Ozaki Y; Yuzawa Y
Heart Vessels; 2013 Jul; 28(4):473-9. PubMed ID: 22914904
[TBL] [Abstract][Full Text] [Related]
9. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
[TBL] [Abstract][Full Text] [Related]
10. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
[TBL] [Abstract][Full Text] [Related]
11. Left atrial volume and adverse cardiovascular outcomes in unselected patients with and without CKD.
Hee L; Nguyen T; Whatmough M; Descallar J; Chen J; Kapila S; French JK; Thomas L
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1369-76. PubMed ID: 24923578
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.
Jalal D; Chonchol M; Etgen T; Sander D
J Nephrol; 2012; 25(5):719-25. PubMed ID: 22038335
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
Dupont M; Wu Y; Hazen SL; Tang WH
Circ Heart Fail; 2012 Sep; 5(5):602-9. PubMed ID: 22899766
[TBL] [Abstract][Full Text] [Related]
14. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
15. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
Chaikriangkrai K; Nabi F; Mahmarian JJ; Chang SM
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1619-26. PubMed ID: 26243534
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.
Tang WH; Wu Y; Hartiala J; Fan Y; Stewart AF; Roberts R; McPherson R; Fox PL; Allayee H; Hazen SL
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):516-22. PubMed ID: 22075249
[TBL] [Abstract][Full Text] [Related]
19. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
[TBL] [Abstract][Full Text] [Related]
20. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
